Global Decentralized Clinical Trial (DCT) Growth Opportunities
Strategic Partnering and M&A Activity in At-home Monitoring Solutions Gain Momentum
06-Jul-2021
North America
Market Research
PBBD-01-00-00-00
HC03430-NA-MT_25562
Frost & Sullivan presents post–COVID-19 growth opportunities and strategic imperatives for the global decentralized clinical trials (DCT) market, covering the market’s maturity, key participants, adoption drivers and restraints, and recent mergers and acquisitions. The report identifies initiatives by major global contract research organizations (CROs) toward DCT adoption; estimates growth patterns for the next 5 years based on detailed analyses of drug and biologics interventional trials, COVID-19–triggered adoption of DCT by sponsors and CROs to continue the disrupted trial operations; and the expected cost-benefit associated with the reduction in site-management burden. The analysis includes regional drivers and challenges of adoption based on select socio-economic and industry parameters.
The DCT market was in a nascent stage prior to the COVID-19 pandemic. The accelerated adoption witnessed during the pandemic outbreak in 2020 was mainly due to restricted mobility of site investigators, clinical research associates, and patients to participate in the trials. To ensure patient safety, most sponsors and CROs adopted digital tools to support trial operations that included telemedicine, remote source data verification, and sensor/mobile technology-enabled direct data-capture solutions. Recent initiatives conducted by the Decentralized Trials & Research Alliance have increased awareness of DCTs globally and catapulted their adoption, especially in North America. The evolving regulations supporting the ease of implementing technologies that enable DCT delivery in Europe and other regions will drive adoption.
However, adoption of decentralized trials is challenged by concerns about data privacy, scalability, and seamless implementation across different continents. Need has increased to support decentralized trials through cloud-based platform solutions that are fit to purpose. CROs building decentralized trial capabilities are partnering with technology vendors to overcome these challenges. Online training modules for patients and secure technology for at-home trial monitoring through devices and sensors have been driving the adoption of decentralized trials after the pandemic. Home health services patients with physical disabilities and restricted access due to location can promote retention in clinical trials. Partnering with home health service providers supported by nurses trained in use of portable equipment will facilitate smooth DCT implementation. Additionally, CROs are focused on innovating trial enrollment and patient engagement strategies by exploring multiple channels, such as use of advocacy groups, social media, and online physician referral systems.
Author: Meghna Hiren Thakkar
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Decentralized Clinical Trial (DCT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Definition: Evolving Clinical Trial Models
Scope of Analysis and Segmentation
COVID-19 Impact on the Clinical Trials Industry
Key Growth Metrics for DCT Market
Vendor Ecosystem for DCT Market
Competitive Trends
Growth Drivers for DCT Market
Growth Restraints for DCT Market
Regulatory Trends, Global DCT Market
Business Model Trend, Global DCT Market
Partnership Trends, Global DCT Market
Key Investments Trends, Global DCT Market
M&A Trends, Global DCT Market
M&A Trends, Global DCT Market (continued)
Forecast Assumptions, DCT Market
Revenue Forecast, DCT Market
Forecast Discussion, Global DCT Market
Forecast Discussion, Global DCT Market (continued)
Revenue Forecast by Region, DCT Market
Revenue Forecast Analysis by Region, DCT Market
Revenue Forecast Analysis by Region, DCT Market (continued)
Growth Opportunity 1: Cloud-based Platform to Achieve Scalability and Workflow Standardization, 2021
Growth Opportunity 1: Cloud-based Platform to Achieve Scalability and Workflow Standardization, 2021 (continued)
Growth Opportunity 2: At-home Patient Monitoring for Infectious Disease Trials, 2021
Growth Opportunity 2: At-home Patient Monitoring for Infectious Disease Trials, 2021 (continued)
Growth Opportunity 3: Omni-channel Recruitment to Expand Patient Reach and Ensure Diversity, 2021
Growth Opportunity 3: Omni-channel Recruitment to Expand Patient Reach and Ensure Diversity, 2021 (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.